Molecular and Cellular Therapies View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2013

PUBLISHER

BioMed Central

LANGUAGE

en

HOMEPAGE

http://molcelltherapies.biomedcentral.com/

Recent publications latest 20 shown

  • 2016-12 Albumin-based drug delivery: harnessing nature to cure disease
  • 2016-12 The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
  • 2016-12 Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules
  • 2015-12 Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling
  • 2015-12 Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
  • 2015-12 Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach
  • 2015-12 Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
  • 2015-12 A prospective, randomized, three arm, open label study comparing the safety and efficacy of PP110, a novel treatment for hemorrhoids to preparation-H® maximum strength cream in the treatment of grade 2–3 hemorrhoids
  • 2015-12 Polymeric nanocarriers for the treatment of systemic iron overload
  • 2015-12 The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target
  • 2015-12 Proteomic analysis of extracellular vesicles from medullospheres reveals a role for iron in the cancer progression of medulloblastoma
  • 2014-12 Gene therapy for cancer: present status and future perspective
  • 2014-12 Harnessing RNAi nanomedicine for precision therapy
  • 2014-12 Therapeutic opportunities for targeting microRNAs in cancer
  • 2014-12 Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy
  • 2014-12 Application of circulating tumor cells scope technique on circulating tumor cell research
  • 2014-12 Human lung telocytes could promote the proliferation and angiogenesis of human pulmonary microvascular endothelial cells in vitro
  • 2014-12 Platelet dysfunction in injured patients
  • 2014-12 Low pH of interstitial fluid around hippocampus of the brain in diabetic OLETF rats
  • 2014-12 Role of solute carriers in response to anticancer drugs
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B0000X", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Biomedicine, general", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B12020", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Gene Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B1700X", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Molecular Medicine", 
            "type": "DefinedTerm"
          }
        ], 
        "description": "

    Molecular and Cellular Therapies (MCT) is the frontline journal for molecular mechanisms, preclinical and clinical research and development of gene-, peptide-, protein-, and cell-based therapies, including target identification and validation, safety, toxicity, efficacy, efficiency, pharmacokinetics, metabolism, formulation, delivery, pharmacovigilance, biomarkers, new drug application. MCT, central to clinical and translational medicine, will integrate genetics, cell biology, medicine, drug development, therapeutics, and biotechnology to improve the prognosis of patients.

    ", "editor": [ { "familyName": "Petersen", "givenName": "Bryon", "type": "Person" } ], "id": "sg:journal.1049594", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2052-8426" ], "license": "Fully Open Access", "name": "Molecular and Cellular Therapies", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "49594" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "40591" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2013247783" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101624707" ] } ], "publisher": { "name": "BioMed Central", "type": "Organization" }, "publisherImprint": "BioMed Central", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1049594" ], "sdDataset": "journals", "sdDatePublished": "2021-01-19T05:00", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "2013", "type": "Periodical", "url": "http://molcelltherapies.biomedcentral.com/" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1049594'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1049594'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1049594'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1049594'


     

    This table displays all metadata directly associated to this object as RDF triples.

    55 TRIPLES      20 PREDICATES      26 URIs      19 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1049594 schema:about sg:ontologies/product-market-codes/B0000X
    2 sg:ontologies/product-market-codes/B12020
    3 sg:ontologies/product-market-codes/B1700X
    4 schema:description <p>Molecular and Cellular Therapies (MCT) is the frontline journal for molecular mechanisms, preclinical and clinical research and development of gene-, peptide-, protein-, and cell-based therapies, including target identification and validation, safety, toxicity, efficacy, efficiency, pharmacokinetics, metabolism, formulation, delivery, pharmacovigilance, biomarkers, new drug application. MCT, central to clinical and translational medicine, will integrate genetics, cell biology, medicine, drug development, therapeutics, and biotechnology to improve the prognosis of patients.</p>
    5 schema:editor Nd10eec7ca7ff4e6b83cc83d4a7ed55d6
    6 schema:inLanguage en
    7 schema:isAccessibleForFree true
    8 schema:issn 2052-8426
    9 schema:license Fully Open Access
    10 schema:name Molecular and Cellular Therapies
    11 schema:productId N0fb39d953358468c9290d5ae9921e277
    12 N25edcfeed1a44ec59d62ba6257ce281d
    13 N46fcf7687035420789e7c72b18790654
    14 Nf9e8dc3e4d154e5c88a1d550c95c44bc
    15 schema:publisher Ne397793cfa0f481abcd7ebf46cb9511a
    16 schema:publisherImprint BioMed Central
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1049594
    18 schema:sdDatePublished 2021-01-19T05:00
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher Nf9c2457953a8485ba7f5f713524500d4
    21 schema:startYear 2013
    22 schema:url http://molcelltherapies.biomedcentral.com/
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset journals
    25 rdf:type schema:Periodical
    26 N0fb39d953358468c9290d5ae9921e277 schema:name nlm_unique_id
    27 schema:value 101624707
    28 rdf:type schema:PropertyValue
    29 N25edcfeed1a44ec59d62ba6257ce281d schema:name springer_id
    30 schema:value 40591
    31 rdf:type schema:PropertyValue
    32 N46fcf7687035420789e7c72b18790654 schema:name lccn_id
    33 schema:value 2013247783
    34 rdf:type schema:PropertyValue
    35 N4aabcbe3524f41eebd96dc23b94b06dc schema:familyName Petersen
    36 schema:givenName Bryon
    37 rdf:type schema:Person
    38 Nd10eec7ca7ff4e6b83cc83d4a7ed55d6 rdf:first N4aabcbe3524f41eebd96dc23b94b06dc
    39 rdf:rest rdf:nil
    40 Ne397793cfa0f481abcd7ebf46cb9511a schema:name BioMed Central
    41 rdf:type schema:Organization
    42 Nf9c2457953a8485ba7f5f713524500d4 schema:name Springer Nature - SN SciGraph project
    43 rdf:type schema:Organization
    44 Nf9e8dc3e4d154e5c88a1d550c95c44bc schema:name dimensions_id
    45 schema:value 49594
    46 rdf:type schema:PropertyValue
    47 sg:ontologies/product-market-codes/B0000X schema:inDefinedTermSet sg:ontologies/product-market-codes/
    48 schema:name Biomedicine, general
    49 rdf:type schema:DefinedTerm
    50 sg:ontologies/product-market-codes/B12020 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    51 schema:name Gene Therapy
    52 rdf:type schema:DefinedTerm
    53 sg:ontologies/product-market-codes/B1700X schema:inDefinedTermSet sg:ontologies/product-market-codes/
    54 schema:name Molecular Medicine
    55 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...